Drug recall · November 6, 2019
Ranitidine Tablets USP recall
Why: CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
- Lots / codes
Lot #: NBSB19001DA3, Exp. date 02/2021
- Quantity
- 69696 bottles
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide within the United States
- Initiated
- September 23, 2019 · Voluntary: Firm initiated
- Classified
- October 29, 2019
- Reported
- November 6, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ranitidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.